Skip to main content
. 2017 Jan 14;8(12):19534–19546. doi: 10.18632/oncotarget.14663

Figure 6. MiR-150-5p reduces chemoresistance in EOC cells.

Figure 6

A, B. MTT cell growth rate were performed in miR-150-5p transfectedCaov3 and SKOV3 cells treated with different concentration of Cisplatin or Paclitaxel indicated. C, D. Caov3 and SKOV3 cells were transfected with miR-150-5p or control miRNA for 48 h, then colony formation assays were performed with treatment of Cisplatin or Paclitaxel indicated. *p<0.05 compared with control cells.